Amalgamated Bank’s PAVmed PAVM Stock Holding History

Amalgamated Bank’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26	Closed	-$16K	–	3157
2022 Q1	$16K	Sell	26 -2	-7%	-$1.49K	﹤0.01%	2862
2021 Q4	$31K	Sell	28 -1	-3%	-$2.17K	﹤0.01%	2131
2021 Q3	$110K	Sell	29 -1	-3%	-$3.15K	﹤0.01%	2071
2021 Q2	$87K	Buy	+30	New	+$70.9K	﹤0.01%	2126

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amalgamated Bank's PAVM Position: Q2 2022 in Review

Amalgamated Bank sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 26 shares — an estimated $16K sold.

Amalgamated Bank first reported a position in PAVM in Q2 2021 and held it in 4 quarters. The position peaked at $110K in Q3 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

Amalgamated Bank reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
Amalgamated Bank sold 26 PAVmed shares in Q2 2022, an estimated $16K.
Amalgamated Bank first reported a position in PAVmed in Q2 2021 and held it in 4 quarters.
Amalgamated Bank's PAVmed position peaked at $110K in Q3 2021.
73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.